Hong Li

Prof. Hong Li


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
PHPing He
Ping He
QZQuan Zhong
Quan Zhong
YGYao Ge
Yao Ge
ZGZhenzhao Guo
Zhenzhao Guo
JTJinhuan Tian
Jinhuan Tian
CZChangren Zhou
Changren Zhou

5 December 2022 in ACS Nano
Verified
Journal Article
Closed access
KLKun Liu
Kun Liu
LLLin Li
Lin Li
JCJingsheng Chen
Jingsheng Chen
YLYizhi Li
Yizhi Li
WWWei Wen
Wei Wen
BLBinghong Luo
Binghong Luo

16 March 2022 in Biomaterials
Verified
Journal Article
Closed access
SLShimei Li
Shimei Li
ZCZengzhen Chen
Zengzhen Chen
LTLongfei Tan
Longfei Tan
QWQiong Wu
Qiong Wu
XRXiangling Ren
Xiangling Ren
XMXianwei Meng
Xianwei Meng

1 July 2018 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
XLXueshi Luo
Xueshi Luo
ZGZhenzhao Guo
Zhenzhao Guo
PHPing He
Ping He
TCTian Chen
Tian Chen
LLLihua Li
Lihua Li
HLHong Li
Hong Li

1 September 2019 in Cancer Letters
Verified
Journal Article
Closed access
ZSZhen Song
Zhen Song
TLTengfei Liu
Tengfei Liu
JCJing Chen
Jing Chen
CGChao Ge
Chao Ge
FZFangyu Zhao
Fangyu Zhao
HLHong Li
Hong Li

30 October 2018 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
CCCong Chen
Cong Chen
CGChao Ge
Chao Ge
ZLZheng Liu
Zheng Liu
LLLiangyu Li
Liangyu Li
FZFangyu Zhao
Fangyu Zhao
JLJinjun Li
Jinjun Li
Hepatocellular carcinoma (HCC) is one of the most common malignant cancers with a high incidence and high mortality in East Asia. Identifying biomarkers and clarifying the regulatory mechanisms of HCC are of great importance. Herein, we report the role and mechanism of activating transcription factor 3 (ATF3), a member of the ATF/cAMP-responsive element-binding protein family of transcription factors in HCC. ATF3 overexpression vector and shRNAs were transfected into HCC cancer cells to upregulate or downregulate ATF3 expression. In vitro and in vivo assays were performed to investigate the functional role of ATF3 in hepatocellular carcinoma. RNA-Seq was performed to screen the differentially expressed genes downstream of ATF3. The dual-luciferase reporter assay, chromatin immunoprecipitation (Ch-IP) analysis and functional rescue experiments were used to confirm the target gene regulated by ATF3. Tissue microarrays (TMAs) comprising 236 human primary HCC tissues were obtained and immunohistochemical staining were carried out to analyze the clinical significance of ATF3. The results indicate that ATF3 significantly inhibited the proliferation and mobility of HCC cells both in vitro and in vivo. Cysteine-rich angiogenic inducer 61 (CYR61) is a key target for transcriptional regulation by ATF3. Both ATF3 and CYR61 were consistently downregulated in human HCC tissues, and their expression levels were significantly and positively correlated with each other. Our findings indicate that ATF3 functions as a tumor suppressor in HCC through targeting and regulating CYR61.